CREB3L1 as a potential biomarker predicting response of triple negative breast cancer to doxorubicin-based chemotherapy

Overview of attention for article published in BMC Cancer, August 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (52nd percentile)
Above-average Attention Score compared to outputs of the same age and source (64th percentile)

So far, Altmetric has seen 6 tweets from 5 users, with an upper bound of 39,284 followers.

RT @JacksonImmunoR: CREB3L1 as a potential biomarker predicting response of triple negative breast cancer to doxorubicin-based chemotherapy…

CREB3L1 as a potential biomarker predicting response of triple negative breast cancer to doxorubicin-based chemotherapy #cancerresearch #breastcancer #JIRSecondaryAntibodies #openaccess https://t.co/Ya5EYPe9MH

RT @BMC_series: #BMCCancer recently published an article on a potential biomarker in triple negative #breastcancer that indicates a positiv…

RT @YanPengB553S: Collaboration of UTSW Pathology and Molecular Genetic Department on a potential predictive biomarker for triple negative…

This page shows the most recent tweets that mention this research output.

Click here to find out how to access more activity, including 2 additional tweets.